Found: 41
Select item for more details and to access through your institution.
Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 9, p. 1701, doi. 10.1007/s00432-017-2428-0
- By:
- Publication type:
- Article
Survival of de novo stage IV breast cancer patients over three decades.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 3, p. 509, doi. 10.1007/s00432-016-2306-1
- By:
- Publication type:
- Article
Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 12, p. 2047, doi. 10.1007/s00432-013-1518-x
- By:
- Publication type:
- Article
Short-term and long-term outcome of radiological-guided insertion of central venous access port devices implanted at the forearm: a retrospective monocenter analysis in 1704 patients.
- Published in:
- European Radiology, 2015, v. 25, n. 3, p. 606, doi. 10.1007/s00330-014-3417-1
- By:
- Publication type:
- Article
Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-term prospective outcome data using EndoPredict as risk stratification and chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 207, n. 1, p. 119, doi. 10.1007/s10549-024-07346-2
- By:
- Publication type:
- Article
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 23, doi. 10.1007/s10549-020-05782-4
- By:
- Publication type:
- Article
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18).
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 183, n. 2, p. 419, doi. 10.1007/s10549-020-05755-7
- By:
- Publication type:
- Article
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 2, p. 319, doi. 10.1007/s10549-018-5008-3
- By:
- Publication type:
- Article
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
ABC7 Consensus: Assessment by a German Group of Experts.
- Published in:
- Breast Care, 2024, v. 19, n. 2, p. 116, doi. 10.1159/000535997
- By:
- Publication type:
- Article
Iyengar-Yoga Compared to Exercise as a Therapeutic Intervention during (Neo)adjuvant Therapy in Women with Stage I–III Breast Cancer: Health-Related Quality of Life, Mindfulness, Spirituality, Life Satisfaction, and Cancer-Related Fatigue.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2016, v. 2016, p. 1, doi. 10.1155/2016/5931816
- By:
- Publication type:
- Article
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-13038-3
- By:
- Publication type:
- Article
Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1093/jncics/pkz085
- By:
- Publication type:
- Article
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literature.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3317, doi. 10.3390/cancers12113317
- By:
- Publication type:
- Article
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 3021, doi. 10.3390/cancers12103021
- By:
- Publication type:
- Article
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry.
- Published in:
- Cancers, 2019, v. 11, n. 1, p. 10, doi. 10.3390/cancers11010010
- By:
- Publication type:
- Article
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 158, n. 1, p. 59, doi. 10.1007/s10549-016-3850-8
- By:
- Publication type:
- Article
First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer.
- Published in:
- Archives of Gynecology & Obstetrics, 2020, v. 302, n. 6, p. 1461, doi. 10.1007/s00404-020-05771-4
- By:
- Publication type:
- Article
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Luminal Metastatic Breast Cancer: Current Concepts and Future Approaches.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer.
- Published in:
- Breast Care, 2021, v. 16, n. 2, p. 108, doi. 10.1159/000515701
- By:
- Publication type:
- Article
International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus – Assessment by a German Group of Experts.
- Published in:
- Breast Care, 2020, v. 15, n. 1, p. 82, doi. 10.1159/000505957
- By:
- Publication type:
- Article
Management of Adverse Events Due to Cyclin-Dependent Kinase 4/6 Inhibitors.
- Published in:
- Breast Care, 2019, v. 14, n. 2, p. 86, doi. 10.1159/000499534
- By:
- Publication type:
- Article
Molecular Tumor Boards.
- Published in:
- 2018
- By:
- Publication type:
- Question & Answer
ABC4 Consensus: Assessment by a German Group of Experts.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
Highlights from ABC4 - Bridging the Gap.
- Published in:
- 2017
- By:
- Publication type:
- Proceeding
Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer.
- Published in:
- Breast Care, 2016, v. 11, n. 3, p. 174, doi. 10.1159/000447417
- By:
- Publication type:
- Article
ABC3 Consensus: Assessment by a German Group of Experts.
- Published in:
- 2016
- By:
- Publication type:
- Proceeding
Nipple-Sparing Mastectomy – Extended Indications and Limitations.
- Published in:
- Breast Care, 2010, v. 5, n. 4, p. 253, doi. 10.1159/000318186
- By:
- Publication type:
- Article
PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0442-0
- By:
- Publication type:
- Article
MRI based neuroanatomical segmentation in breast cancer patients: leptomeningeal carcinomatosis vs. oligometastatic brain disease vs. multimetastastic brain disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 5, p. 741, doi. 10.2967/jnumed.115.161034
- By:
- Publication type:
- Article
The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges.
- Published in:
- Disease Markers, 2017, p. 1, doi. 10.1155/2017/4934608
- By:
- Publication type:
- Article
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00667-x
- By:
- Publication type:
- Article
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00561-y
- By:
- Publication type:
- Article
Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e439, doi. 10.1634/theoncologist.2019-0493
- By:
- Publication type:
- Article
Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1514, doi. 10.1634/theoncologist.2019-0019
- By:
- Publication type:
- Article
Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1.
- Published in:
- PLoS ONE, 2017, v. 12, n. 9, p. 1, doi. 10.1371/journal.pone.0183917
- By:
- Publication type:
- Article
Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: results from the prospective randomized ADEBAR trial.
- Published in:
- Breast Cancer (13406868), 2017, v. 24, n. 2, p. 319, doi. 10.1007/s12282-016-0706-3
- By:
- Publication type:
- Article